Shares of Alignment Healthcare (NASDAQ:ALHC) rose 3.2%

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report ) rose 3.2% on Friday. The company traded as high as $11.91 and last traded at $11.75. About 232,180 shares traded hands during mid-day trading, down 75% from the average daily volume of 938,130 shares. Shares previously closed at $11.39.

The Wall Street analyst weighs in

A number of research firms have commented on ALHC. Piper Sandler reissued an “overweight” rating and issued a $10.00 target price (up previously from $8.00) on shares of Alignment Healthcare in a research note on Tuesday, August 6th. Baird RW raised Alignment Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. TD Cowen lifted their price target on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research note on Tuesday, August 6th. Bank of America upgraded Alignment Healthcare from a “neutral” rating to a “buy” rating and upped their price objective for the company from $7.75 to $11.00 in a research report on Thursday. May 30. Finally, Robert W. Baird raised their price target on Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 14th. . One analyst has rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Moderate Buy” and a consensus price target of $9.83, according to MarketBeat.com.

Check out our latest report on Alignment Healthcare

Healthcare alignment trading up 1.0%

The company has a debt-to-equity ratio of 1.70, a quick ratio of 1.61, and a current ratio of 1.61. The firm has a 50-day moving average of $9.37 and a 200-day moving average of $7.40. The firm has a market cap of $2.20 billion, a P/E ratio of -13.56 and a beta of 1.43.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report ) last released its earnings results on Thursday, August 1st. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.01. The company had revenue of $681.29 million for the quarter, compared to the consensus estimate of $637.66 million. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 101.10%. The company’s revenue for the quarter was up 47.3% year over year. During the same period in the prior year, the firm earned ($0.15) earnings per share. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.67 EPS for the current fiscal year.

Indoor activity

In related news, CFO Robert Thomas Freeman sold 22,100 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $10.00, for a total value of $221,000.00. Following the sale, the chief financial officer now directly owns 497,329 shares of the company’s stock, valued at $4,973,290. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC’s website. In related news, CFO Robert Thomas Freeman sold 22,100 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $10.00, for a total value of $221,000.00. Following the completion of the sale, the chief financial officer now owns 497,329 shares of the company’s stock, valued at $4,973,290. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible via this hyperlink. Also, insider Christopher J. Joyce sold 15,034 shares of the company’s stock in a transaction dated Monday, July 15th. The shares were sold at an average price of $9.05, for a total transaction of $136,057.70. Following the completion of the sale, the insider now owns 406,912 shares of the company’s stock, valued at $3,682,553.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 268,639 shares of company stock worth $2,676,719. Insiders own 6.60% of the company’s shares.

Hedge Funds Influence Healthcare Alignment

Hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new stake in shares of Alignment Healthcare in the 1st quarter worth $57,000. Principal Financial Group Inc. bought a new position in Alignment Healthcare in the first quarter valued at about $57,000. Victory Capital Management Inc. boosted its holdings in shares of Alignment Healthcare by 17.9% during the 4th quarter. Victory Capital Management Inc. now owns 12,935 shares of the company’s stock valued at $111,000 after acquiring an additional 1,962 shares during the last quarter. Aigen Investment Management LP raised its stake in shares of Alignment Healthcare by 18.5% in the fourth quarter. Aigen Investment Management LP now owns 19,764 shares of the company’s stock worth $170,000 after acquiring an additional 3,092 shares during the period. Finally, Allspring Global Investments Holdings LLC boosted its holdings in shares of Alignment Healthcare by 9.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after purchasing an additional 3,334 shares during the last quarter. 86.19% of the shares are currently held by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

(Get a free report)

Alignment Healthcare, Inc, a Medicare technology advantage company, operates a consumer-centric healthcare platform for seniors in the United States. It offers personalized medical care designed to meet the needs of a wide range of seniors through its affordable Medicare plans. The company was founded in 2013 and is headquartered in Orange, California.

See Also

Get news and reviews for Alignment Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Alignment Healthcare and related companies with MarketBeat.com ‘s FREE daily email newsletter.